Good results in MF02

The second study verifies Strokefinders ability to distinguish between bleeding and clot Medfields second study, MF02, in order to further verify micro waves ability to distinguish between bleeding and clotting… läs mer

Four questions

Four questions to Andreas Fhager by Gunilla Brocker The research project “Strokefinder” will be tested in the NHS hospitals in the UK and Ireland. Associate Professor Andreas Fhager and Professor… läs mer

Strokefinder in GP

Article published in the newspaper Göteborgs-Posten (GP) “Hat” helps stroke patients By Lotta Hohner Every year, thousands of people suffer of stroke in Sweden. Using patented technology from Chalmers Univerity… läs mer

MF 03 approved

Medfields monitoring study approved by the Swedish FDA and Ethics Board The development of Strokefinder continues. Now as a supervisory Strokefinder (“stroke hat”) for TIA patients, whose study now is… läs mer

Successful appearance

Successful appearance at Akuttmedisinsk seminar in Norway On Sunday, August 26, Medfield Diagnostics’ CEO Patrik Dahlqvist made an appreciated presentation at the Akuttmedisinsk seminar in Oslo. Judging by the extensive… läs mer

Västnytt attention International Stroke Day

On May 8th, the International Stroke Day, Swedish Televison visited Sahlgrenska University Hospital and highlighted the stroke helmet Strokefinder R10. (Only in Swedish)

New Issue closed

On March 27, closed Medfield its new issue. The issue was subscribed by 552 new shareholders, which together provides the Company more than 6.9 million SEK. The issue is followed… läs mer

Positive analysis from Axier

In connection with Medfields issue and listing on AktieTorget the independent research house Axier Equities published an analysis of Medfield Diagnostics, read more (Swedish Only).